Discover B2B leads for Hospitals & Clinics industry
Identify and research relevant prospects for B2B lead generation on Hospitals & Clinics sector. Find their verified contact details to reach out to them, nurture and convert them into paying clients. Streamline the process of filtering B2B prospects by searching for bisinesses based on their specifics like location, name or category.
Businesses
Found 14 in our database
Found 112 in our records

HQ: Northbrook, Illinois, United States
Horizon Therapeutics focuses on the development ofShow more... prescription drugs for mild to moderate pain relief and arthritis.
HQ: Northbrook, Illinois, United States
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Hospitals & Clinics
Business Type: Delisted
Employees: 1001-5000
Rounds: Post-IPO Equity
Last Investment Activity: Dec 12, 2022
Founded Date: 2005
Company Type: For Profit
Stock Symbol: NASDAQ:HZNP
Operating Status: Active
Main email format: ssmith@horizontherapeutics.com (54.5%)
-
John Croatt
Regional Account Director
j*********t@horizontherapeutics.com
-
Liz Gutierrez
l********z@horizontherapeutics.com
-
Susanna Frydryk
s******k@horizontherapeutics.com
-
Customer Service
customerservice@horizontherapeutics.com
-
Unclassified inbox
jwhalen@horizonpharma.com

HQ: New York, New York, United States
Loxo Oncology is a biopharmaceutical company focusShow more...ed on targeted cancer therapies for genetically-defined patient populations.
HQ: New York, New York, United States
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Hospitals & Clinics
Business Type: Public
Employees: 501-1000
Rounds: Post-IPO Equity
Last Investment Activity: Oct 17, 2022
Founded Date: 2013
Company Type: For Profit
Stock Symbol: NASDAQ:LOXO
Operating Status: Active
Main email format: ssmith@loxooncology.com (87.5%)
-
Ipsita Roy
Sr. Program/Project Manager
i**y@loxooncology.com
-
Nisha Nanda
Director, Clinical Science and Development
n***a@loxooncology.com
-
General Inquiries
info@loxooncology.com
-
Unclassified inbox
clinicaltrials@loxooncology.com

HQ: Cambridge, Massachusetts, United States
Cullinan Oncology is a developer of an externally Show more...sourced cancer therapeutics used to end a drug program quickly.
HQ: Cambridge, Massachusetts, United States
Specialized In: Pharmaceuticals, Biotechnology, Medical Devices, Hospitals & Clinics
Business Type: Public
Employees: 11-50
Rounds: Post-IPO Equity
Last Investment Activity: Mar 14, 2024
Founded Date: 2017
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:CGEM
Operating Status: Active
Main email format: ssmith@cullinanoncology.com (100.0%)

HQ: Dublin, Dublin, Ireland
Shire biotechnology company that focuses on servinShow more...g people with rare diseases.
HQ: Dublin, Dublin, Ireland
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Hospitals & Clinics, Wellness
Acquired by: Takeda
Business Type: Public
Employees: 10001+
Rounds: Venture - Series Unknown
Last Investment Activity: May 14, 2024
Founded Date: 1986
Number of Exits: 4
Company Type: For Profit
Stock Symbol: NASDAQ:SHPG
Operating Status: Closed
Main email format: ssmith@shire.com (100.0%)
-
Victor Otcheretko
v*********o@shire.com
-
General Inquiries
info@shirehousing.com
-
General Inquiries
info@shirefoods.com
-
Unclassified inbox
golf@theshirelondon.com
-
Unclassified inbox
shire@woodanilling.wa.gov.au
-
Unclassified inbox
abcdefghij@shire.com

HQ: San Diego, California, United States
Rakuten Medical is a biotechnology company that deShow more...velops precision, cell-targeting investigational therapies.
HQ: San Diego, California, United States
Specialized In: Pharmaceuticals, Healthcare & Medical, Hospitals & Clinics
Business Type: Private
Employees: 101-250
Rounds: Series E
Last Investment Activity: Mar 26, 2024
Founded Date: 2010
Company Type: For Profit
Operating Status: Active
Main email format: ssmith@rakuten-med.com (100.0%)
-
Unclassified inbox
info.tw@rakuten-med.com
-
Unclassified inbox
j.d@rakuten-med.com
-
General Inquiries
info@rakuten-med.com

HQ: London, England, United Kingdom
BTG is a global healthcare company focused on InteShow more...rventional Medicine.
HQ: London, England, United Kingdom
Specialized In: Pharmaceuticals, Hospitals & Clinics, Healthcare & Medical, Manufacturing & Industrial
Business Type: Private
Employees: 1001-5000
Rounds: Venture - Series Unknown
Last Investment Activity: Jan 27, 2020
Founded Date: 1948
Number of Exits: 2
Company Type: For Profit
Operating Status: Closed

HQ: Seattle, Washington, United States
CTI BioPharma is a biopharmaceutical company develShow more...oping oncology products for the treatment of blood-related cancers.
HQ: Seattle, Washington, United States
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Hospitals & Clinics
Business Type: Delisted
Employees: 101-250
Rounds: Post-IPO Debt
Last Investment Activity: Jun 26, 2023
Founded Date: 1991
Company Type: For Profit
Stock Symbol: NASDAQ:CTIC
Operating Status: Active

HQ: Chapel Hill, North Carolina, United States
Tenax Therapeutics focuses on identifying and deveShow more...loping treatments that address cardiovascular and pulmonary diseases.
HQ: Chapel Hill, North Carolina, United States
Specialized In: Pharmaceuticals, Healthcare & Medical, Hospitals & Clinics
Business Type: Public
Employees: 11-50
Rounds: Post-IPO Equity
Last Investment Activity: Feb 20, 2024
Founded Date: 1967
Company Type: For Profit
Stock Symbol: NASDAQ:TENX
Operating Status: Active
Main email format: sarah.smith@tenaxthera.com (100.0%)
-
Stuart Rich
CMO
s*********h@tenaxthera.com
-
Michael B. Jebsen
CFO
-
Eliot Lurier
Interim Chief Financial Officer
-
Chris Giordano
President & CEO
-
General Inquiries
info@tenaxthera.com

HQ: Wadenswil, Zurich, Switzerland
Numab is a biotechnology company that offers antibShow more...ody-based therapeutics for the treatment of severe diseases.
HQ: Wadenswil, Zurich, Switzerland
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Health Diagnostics, Hospitals & Clinics
Business Type: Private
Employees: 51-100
Rounds: Series C
Last Investment Activity: Feb 13, 2024
Founded Date: 2011
Number of Exits: 1
Company Type: For Profit
Operating Status: Active
Main email format: s.smith@numab.com (100.0%)
-
David Urech
CSO, and Co-CEO, Founder
d*****h@numab.com
T***********************************************************************************m
-
Oliver Middendorp
CBO, Co-CEO, and Co-Founder
-
Peter Lichtlen
CMO and Co-Founder
-
Tea Gunde
Head of Pharmacology
-
Sebastian Meyer
Chief Operating Officer
-
Roland Helfenstein
Chief Financial Officer
-
General Inquiries
info@numab.com
-
Admin Team
admin@numab.com
-
Legal Department
legal@numab.com

HQ: Planegg, Bayern, Germany
4SC discovers and develops targeted, small-moleculShow more...e drugs for the treatment of cancer and autoimmune diseases.
HQ: Planegg, Bayern, Germany
Specialized In: Pharmaceuticals, Hospitals & Clinics
Business Type: Public
Employees: 51-100
Rounds: Post-IPO Equity
Last Investment Activity: Mar 22, 2024
Founded Date: 1997
Company Type: For Profit
Stock Symbol: FRA:VSC
Operating Status: Active
-
Jason Loveridge
Chief Executive Officer
-
Susanne Danhauser-Riedl
Chief Medical Officer
-
Frank Hermann
Chief Development Officer
-
Unclassified inbox
public@4sc.com
-
Unclassified inbox
ir-pr@4sc.com
-
General Inquiries
info@4sc.com
-
Unclassified inbox
ursula.herz@4sc.com

HQ: San Diego, California, United States
Adamis Pharmaceuticals is a neuro-biotechnology coShow more...mpany developing treatments for neuro-based disorders.
HQ: San Diego, California, United States
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Hospitals & Clinics
Business Type: Public
Employees: 11-50
Rounds: Post-IPO Equity
Last Investment Activity: Aug 4, 2023
Founded Date: 2006
Company Type: For Profit
Stock Symbol: NASDAQ:ADMP
Operating Status: Active
-
Dennis J. Carlo
Founder & CEO
-
David C. Benedicto
Chief Financial Officer
-
General Inquiries
info@adamispharma.com

HQ: Houston, Texas, United States
ImmunoMet Therapeutics is a biopharmaceutical compShow more...any that develops and commercializes oncology products for cancer patients.
HQ: Houston, Texas, United States
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Hospitals & Clinics
Business Type: Private
Employees: 1-10
Rounds: Series B
Last Investment Activity: Jul 26, 2021
Founded Date: 2015
Company Type: For Profit
Operating Status: Active
-
Edward Garmey
Consultant CMO
-
Sungwuk Kim
CEO
-
Revati Shreeniwas
Chief Medical Officer
-
General Inquiries
info@immunomet.com

HQ: Cambridge, Cambridgeshire, United Kingdom
Phico Therapeutics is a developer of novel platforShow more...m technology designed to overcome antibacterial resistance.
HQ: Cambridge, Cambridgeshire, United Kingdom
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Hospitals & Clinics
Business Type: Private
Employees: 1-10
Rounds: Venture - Series Unknown
Last Investment Activity: Feb 1, 2022
Founded Date: 2000
Company Type: For Profit
Operating Status: Active
-
Heather Fairhead
Founder & CEO
-
Katy Pitts
Facility manager and senior R&D scientist
-
James Cass
Manager of research and development
-
Anthony Martin
Chairman & Non Executive Director
-
General Inquiries
info@phicotx.co.uk
-
Admin Team
admin@phicotx.co.uk
-
General Inquiries
info@phicotherapeutics.co.uk

HQ: Vancouver, British Columbia, Canada
Novelion Therapeutics Inc, formerly QLT Inc., is aShow more... Canada-based biopharmaceutical company
HQ: Vancouver, British Columbia, Canada
Specialized In: Pharmaceuticals, Biotechnology, Hospitals & Clinics
Business Type: Public
Employees: 251-500
Rounds: Post-IPO Debt
Last Investment Activity: Aug 25, 2021
Founded Date: 1981
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:NVLN
Operating Status: Active
-
Robert L. Butchofsky
President & CEO
-
Cameron R. Nelson
CFO
-
Investor Relations
ir@qltinc.com
- «
- 1
- »
We’re in beta testing! Sign up for free to unlock all the information on this page — no credit card required.